CL Colgate-Palmolive Company
CL Colgate-Palmolive Company
Consumer Defensive · Household & Personal Products
Desk view
Market read
POC $84.36 · VWAP $86.62 · +8.6% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $29.7M sold last open-market sell Wallace Noel R.
Cluster CEO, Director sold $30.1M, Aug 6–7
Coverage
1 watchlist
CL Price Structure
Loading timeframes…
Peers
Every watchlist CL belongs to, members best 30-day change first — CL highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
Reported the quarter ending 2026-06-30: revenue $5.36B, diluted EPS $0.86, net income $693M (SEC filing). Across the print the stock moved -1.9% (close before → first close after).
full note →Against street estimates
How CL's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about CL from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 3 days ago · Oct 20
- COLGATE-PALMOLIVE COMPANY (CL) Stock, Price, News, Quotes, Forecast and Insights | MSN Money
- CL Stock Quote Price and Forecast | CNN
- What You Need to Know Ahead of Colgate-Palmolive Earnings Release
- Colgate-Palmolive - CL - Stock Price & News | The Motley Fool
- ETFs Are Net Sellers of Colgate-Palmolive (CL) on Oct. 13
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
CL research tape
18 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.